(The Mount desert Hospital / Mount desert School of Medicine) Researchers at Mount desert School of Medicine in New royalty hit institute that sorafenib (Nexavar) helps patients with modern liver cancer springy most 44 proportionality individual compared with patients who did not obtain the anti-cancer drug. The findings, publicised in the July 23, 2008, supply of the New England Journal of Medicine, is a momentous front in the direction of liver cancer, which is the ordinal drive of cancer modification globally, ofttimes resulting in modification within a assemblage of diagnosis.

Tags: Cancer, Hospital, Medicine, New York, School Of Medicine